Kyverna Therapeutics: sell signal, but setup doesn't favor new entries

Kyverna Therapeutics is in week 1 of a fresh sell signal, ranking 26th among 114 US sell signals. Signal strength stands at 6 out of 100 — an indecisive week — but the weekly structure is bearish and the daily CMF in distribution confirms ongoing selling pressure. The quality band flags trading as not recommended, with the stock above its 200-week moving average and elevated volatility.